Articles that mention AstraZeneca -BoardProspects

AstraZeneca

0 Comments Leave a Comment

1-15 of 45 1 2 3 »
1. Mentioned In 45 Articles
2. Box Urges Stockholders to Support Its Superior Director Nominees at September 9th Annual Meeting
  
  Explore Yahoo! Finance Sep 2 2021 BoardNews
  
  ...breed enterprise IT stack. Founded in 2005, Box simplifies work for leading organizations globally, including AstraZeneca, JLL, and Morgan Stanley. Box is headquartered in Redwood City, CA, with offices in the United Sta...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Annual Meeting KKR
3. Enpro Elects Judith A. Reinsdorf to Board of Directors
  
  Explore Yahoo Finance Sep 1 2021 BoardMoves
  
  ...er. Judy chaired the Governance Committee at both Alexion Pharmaceuticals, until the July 2021 acquisition by AstraZeneca, and at Dun & Bradstreet from 2013 until 2019, when the company was taken private. Ms. Reinsdorf c...
  Read Full Article
  
  Comment
  
  Mentions: Governance Committee acquisition Alexion Pharmaceuticals
4. Box Mails Letter to Stockholders Highlighting Superior Board Leadership and Nominees
  
  Explore businesswire.com Jul 26 2021 BoardNews
  
  ...breed enterprise IT stack. Founded in 2005, Box simplifies work for leading organizations globally, including AstraZeneca, JLL, and Morgan Stanley. Box is headquartered in Redwood City, CA, with offices in the United Sta...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Leadership Investment
5. Biotech Company That Botched Vaccines Faces Investor Revolt
  
  Explore The New York Times Jul 6 2021 BoardNews
  
  ... which had secured a lucrative government contract to manufacture Covid-19 vaccines for Johnson & Johnson and AstraZeneca. “I love this story,” Mr. Cramer said last August, hailing the company’s soaring stock price. “Why...
  Read Full Article
  
  Comment
  
  Mentions: lawsuit Shareholder Lawsuit Johnson & Johnson
6. Waters Corporation Appoints Wei Jiang to Board of Directors
  
  Explore businesswire.com Jun 24 2021 BoardMoves
  
  ...mmittee and responsible for pharma business in China and APAC. He previously held various senior positions at AstraZeneca, culminating in his role as Senior Vice President, China operations. Prior to that, Mr. Jiang serv...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations NYSE AstraZeneca
7. Glaxo CEO Walmsley Buys Time as Strategy Gets Modest Backing
  
  Explore Yahoo! Finance Jun 23 2021 BoardNews
  
  ...ny will be able to follow through on its drug development pipeline, which has languished behind peers such as AstraZeneca Plc.“I am very aware that GSK shares have underperformed for a long period,” Walmsley said Wednesd...
  Read Full Article
  
  Comment
  
  Mentions: Management Sanofi Barclays
8. GSK Set for Crunch Meeting With Shareholders as Activist Pushes for Change
  
  Explore Yahoo Finance Jun 23 2021 BoardNews
  
  ...ront line in the war on COVID”, the BBC said. She will reportedly admit that the company has been eclipsed by AstraZeneca, Pfizer (PFE) and others but that the pandemic is not over and GSK could still catch up. GSK is ex...
  Read Full Article
  
  Comment
  
  Mentions: Management IPO Sanofi
9. GlaxoSmithKline Gains Key Supporters in Potential Proxy Battle
  
  Explore Yahoo! Finance May 21 2021 BoardNews
  
  ...he drug industry. And Elliott often gets what it wants. The fund was instrumental in Alexion's acquisition by AstraZeneca (NASDAQ:AZN) in a $40 billion takeover. It also wanted Bayer AG (XTER:BAYN) to divide its crop sci...
  Read Full Article
  
  Comment
  
  Mentions: Management Proxy Fight acquisition
10. We’re All The Poorer for Shareholders’ Loss of Nerve on Executive Pay
  
  Explore msn.com May 16 2021 BoardBlogs
  
  ... of eye-popping pay packages overcame the threat of voter rebellions at annual general meetings. The board of AstraZeneca asked shareholders to support their decision to award the chief executive, Pascal Soriot, £18m in ...
  Read Full Article
  
  Comment
  
  Mentions: Investment Sky AstraZeneca
11. AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row
  
  Explore Yahoo! Finance May 9 2021 BoardNews
  
  ...3m ($3.2m) and 12m a sum that could rise in line with AstraZeneca's share price... Amid mounting scrutiny of AstraZeneca's (AZ.L) COVID-19 vaccine, the company's CEO is facing pushback from shareholders over a potential...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management ISS
12. Glaxo Defends Strategy in Face of Elliott Management Stake
  
  Explore Start Magazine May 5 2021 BoardNews
  
  ... who has been in post since 2017. The company has lagged behind competitors, notably fellow British drugmaker AstraZeneca Plc, after it moved away from lucrative areas like oncology, which Walmsley has been trying to reb...
  Read Full Article
  
  Comment
  
  Mentions: Management Sanofi stake
13. ‘Obscene’ Bonus Hike for AstraZeneca Boss Prompts Investor Anger
  
  Explore msn.com May 4 2021 BoardNews
  
  ...rebuilt AstraZeneca’s drug portfolio. The firm has faced down several shareholder pay revolts over the years. AstraZeneca pointed out that the pension contributions of Soriot and other executives would be cut to the same...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management ISS
14. While Shareholders Own a Company, it's the Executive Team and Board Who Hold the Power: But if You Want To Cut Fat Cat Pay or Make Firms Go Greener - Vote
  
  Explore msn.com May 2 2021 BoardBlogs
  
  ...t lending to the fossil fuel sector. Unilever, Aviva and Rightmove are also holding their AGMs this week with AstraZeneca, Centrica, BP, Rentokil, Balfour Beatty, Hiscox and Prudential following suit the week after. The ...
  Read Full Article
  
  Comment
  
  Mentions: Barclays Unilever Tesco
15. Activist Investor Elliott's Arrival on the Doorstep of GSK May Require Boss Emma Walmsley to Strengthen the Defenses
  
  Explore msn.com Apr 16 2021 BoardNews
  
  ...ompared with peers on both sides of the Atlantic. The crossover in valuations between its main UK counterpart Astrazeneca and GSK, previously regarded as the UK's top rated big pharma group, has underlined perceived unde...
  Read Full Article
  
  Comment
  
  Mentions: Management Sanofi BHP
16. Astra Plots Post-Covid Future With $39 Billion Alexion Deal
  
  Explore msn.com Dec 12 2020 BoardNews
  
  ... rare diseases. In the sale to AstraZeneca, holders of each Alexion share will receive $60 in cash and 2.1243 AstraZeneca American depositary shares, the U.K. company said in a press release Saturday. The drugmaker will ...
  Read Full Article
  
  Comment
  
  Mentions: Management Goldman Sachs CFO
17. 1-15 of 45 1 2 3 »